LMAO!
$Catalyst Pharmaceuticals (CPRX.US)$ Amazing! a company gets a 3rd party to say its phase 2 data looks great, and that ticker explodes 300%? Then you have this and like $Ardelyx (ARDX.US)$ that get actual FDA approval and it dont move! hehehe so crazy! i mean i still think this does go? its just a matter of when?![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Contrarian7 : exactly, one gets phase 2 data on a rare disease and it explodes, whereas another gets FDA approval for common kidney disease (drug easily worth more than $1B), plus ARDX has sufficient cash flow with $50M capital injection till 2025. ARDX has earnings coming up 31 Oct should easily clear $4.50 afterwards.
Trytosaveabit OP Contrarian7 : Agreed
72783278 Contrarian7 : totally agreed